1, Men are generally at greater risk for cardiovascular disease than are wo
men, particularly with regard to enhanced progression of hypertension and l
oss of renal function. Despite these gender differences in the progression
of hypertension and renal disease in humans and animals, the mechanisms res
ponsible are unknown.
2. Castration in males has been shown to slow the progression of hypertensi
on and ameliorate the loss in renal function. When serum testosterone was m
easured in the developing male spontaneously hypertensive rat (SHR), the pe
ak serum testosterone level at 12 weeks coincided with the time when differ
ences in systolic blood pressure could be measured between intact male SHR
and females or castrated male SHR. Ovariectomy does not affect blood pressu
re in female SHR but testosterone treatment of ovariectomized females for 5
weeks results in exacerbation of hypertension almost to the level found in
intact male SHR. These data strongly suggest a role for androgens in media
ting the gender differences in hypertension.
3. The mechanisms by which androgens could increase blood pressure are not
known. We have recently shown that, at comparable renal perfusion pressures
, there is a hypertensive shift in the pressure-natriuresis relationship in
male SHR compared with females or castrated male SHR, Testosterone treatme
nt of ovariectomized female SHR also causes a rightward shift in the pressu
re-natriuresis relationship.
4. We hypothesize that androgens increase arterial pressure by causing a hy
pertensive shift in the pressure-natriuresis relationship, either by having
a direct effect to increase proximal tubular reabsorption or by activation
of the renin-angiotensin system. We also hypothesize that the enhanced pro
ximal tubular reabsorption leads to a tubuloglomerular feedback-mediated af
ferent vasodilation, which, in combination with the increase in arterial pr
essure, results in glomerular hypertension and renal injury.